Research progress on occupational protection management of tumor chemotherapy care

Abstract

Abstract: The global incidence rate and mortality of cancer are rising rapidly with the aggravation of environmental pollution and population aging,and the demand for chemotherapy in cancer patients has also increased accordingly,but as we all know,chemotherapy drugs are various,special in nature,mostly cytotoxic. In recent years,more and more studies have shown that long-term exposure to anti-tumor drugs will also pose a potential threat to the physical and mental health of clinical nursing workers engaged in tumor chemotherapy. Mastering comprehensive chemotherapy occupational protection knowledge and measurescan effectively reduce or avoid occupational exposure risks. Therefore,by reviewing the research on occupational protection management of chemotherapy at home and abroad,this article intends to review the occupational protection content,occupational hazards and protection status of chemotherapy drugs,and chemotherapy protection management measures,in order to improve the occupational protection awareness of clinical cancer chemotherapy nursing staff,avoid or reduce occupational exposure in clinical work,protect their physical and mental health,and improve the comprehensive labor efficiency of hospitals and society.

Key words: Oncology nurse, Chemotherapy nursing, Occupational protection

CLC Number:

R181.3⁺1

YANG Fan, LIU Ruihong, WANG Juan. Research progress on occupational protection management of tumor chemotherapy care. [J]OCCUPATION AND HEALTH, 2023, 39(19): 2732-2736.

References

[1] CHANG S S.Re:Annual report to the nation on the status of cancer,Part I:National cancer statistics[J].J urol,2020,204(3):618.
[2] WILSON B E,JACOB S,YAP M L,et al.Estimates of global chemotherapy demands and corresponding physician workforce requirements for 2018 and 2040:A population-based study[J].Lancet Oncol,2019,20(6):769-780.
[3] SIMONS A,TOLAND S.Perceived adverse effects from handling systemic anti-cancer therapy agents[J].Br J Nurs,2017,26(16):S38-S44.
[4] HUANG X,GAO C,CAI W,et al.Effect of occupational exposure to antineoplastic drugs on DNA damage in nurses:A cross-sectional study[J].Occup Environ Med,2022,79(4):253-258.
[5] SOHEILI M,JOKAR F,EGHBALI-BABADI M,et al.Exploring the occupational health needs of oncology nurses:A qualitative study[J]. J Educ Health Promot,2021,10:224.
[6] 张敏,徐李卉,刘拓,等.我国医护人员职业卫生防护体系研究[J].中国安全生产科学技术,2018,14(5):51-60.
[7] AL ZOUBI A M,SAIFAN A R,ALRIMAWI I,et al.Challenges facing oncology nurses in Jordan:A qualitative study[J].Int J Health Plann Manage, 2020,35(1):247-261.
[8] 连剑娟,李红.护理职业风险的防护水平与研究现状[J].国际护理学杂志,2007(1):3-6.
[9] XU H,ZHANG M,HUDSON A.Occupational Health Protection for Health Workers in China with lessons learned from the UK:Qualitative interview and policy analysis[J].Saf Health Work,2021,12(3):304-310.
[10] 张敏. 《血源性病原体职业接触防护导则》及其解读[J].中国护理管理,2010,10(7):10-12.
[11] CONNOR T H,LAWSON C C,POLOVICH M,et al.Reproductive health risks associated with occupational exposures to antineoplastic drugs in health care settings:A review of the evidence[J].J Occup Environ Med,2014,56(9):901-910.
[12] SRISINTORN W,GEATER A,POLOVICH M,et al.Factors influencing precautions against antineoplastic drug exposure among nurses and nurse assistants in Thailand[J].Int Arch Occup Environ Health,2021, 94(5):813-822.
[13] 梅小红,陈昌蕊,黄超,等.抗肿瘤药物对我国医务人员健康的影响及其防护研究进展[J].护理研究,2021,35(10):1766-1770.
[14] 黄超,黄小红.抗癌药物对护士的职业危害及其防护管理[J].现代医药卫生,2021,37(2):244-247.
[15] RAMPHAL R,BAINS T,VAILLANCOURT R,et al.Occupational exposure to cyclophosphamide in nurses at a single center[J].J Occup Environ Med,2014,56(3):304-312.
[16] ALEHASHEM M,BANIASADI S.Important exposure controls for protection against antineoplastic agents:Highlights for oncology health care workers[J].Work,2018,59(1):165-172.
[17] WALTON A L,KNEIPP S,LINNAN L,et al.Nursing assistants' use of personal protective equipment regarding contact with excreta contaminated with antineoplastic drugs[J].Oncol Nurs Forum,2019,46(6):689-700.
[18] 刘碧岩. 职业接触化疗药物医护人员白细胞减少相关因素及防控措施[J].中国卫生工程学,2018,17(4):552-553.
[19] 刘银,刘勤东.静脉药物配置中心细胞毒性药物配置的防护措施[J].世界最新医学信息文摘,2019,19(5):202-203.
[20] YU E.Occupational Exposure in Health Care Personnel to Antineoplastic Drugs and Initiation of Safe Handling in Hong Kong:A Literature Review[J].J Infus Nurs,2020,43(3):121-133.
[21] 梁琴,杨长萍,樊安之.肿瘤化疗药物渗漏的预防与处理[J].中华肿瘤防治杂志,2018,25(S1):309-310.
[22] YOON J S,CHOI M,SHIN C Y,et al.Development of a model for chemotherapy-induced alopecia:profiling of histological changes in human hair follicles after chemotherapy[J].J Invest Dermatol,2016, 136(3):584-592.
[23] SAGAWA N,OSHIMA Y,HIRATSUKA T,et al.Role of increased vascular permeability in chemotherapy-induced alopecia:In vivo imaging of the hair follicular microenvironment in mice[J].Cancer Sci, 2020,111(6):2146-2155.
[24] CONNOR T H,LAWSON C C,POLOVICH M,et al.Reproductive health risks associated with occupational exposures to antineoplastic drugs in health care settings a review of the evidence[J].J Occup Environ Med,2014,56(9):901-910.
[25] NASSAN F L,CHAVARRO J E,JOHNSON C Y,et al.Prepregnancy handling of antineoplastic drugs and risk of miscarriage in female nurses[J].Ann Epidemiol,2021,53:95-102.
[26] GHAFOURI-FARD S,SHOOREI H,ABAK A,et al.Effects of chemo-therapeutic agents on male germ cells and possible ameliorating impact of antioxidants[J].Biomed Pharmacother,2021,(142):1-21.
[27] 饶志璟,邓海滨,祝利民,等.化疗药物所致周围神经毒性中西医研究进展[J].世界科学技术-中医药现代化,2020,22(4):1307-1314.
[28] WAS H,BORKOWSKA A,BAGUES A,et al.Mechanisms of Chemotherapy-Induced Neurotoxicity[J].Front Pharmacol,2022,13:1-32.
[29] RAMAZANI M,JAKTAJI R P,SHIRAZI F H,et al.Analysis of apoptosis related genes in nurses exposed to anti-neoplastic drugs[J].BMC Pharmacol Toxicol,2019,20(1):74.
[30] LIN Y,CHANG Y,LIN Y C,et al.Factors Influencing Nurses' Use of Hazardous Drug Safe Handling Precautions[J].Oncol Nurs Forum,2019, 46(3):86-97.
[31] SANTOVITO A,CERVELLA P,DELPERO M.Chromosomal damage in peripheral blood lymphocytes from nurses occupationally exposed to chemicals[J].Hum Exp Toxicol,2014,33(9):897-903.
[32] 郭伟玲,尚鹤睿.中国职业卫生法律体系实施现状研究[J].中国公共卫生管理,2020,36(3):335-338.
[33] GURUSAMY K S,BEST L M,TANGUAY C,et al.Closed-system drug-transfer devices plus safe handling of hazardous drugs versus safe handling alone for reducing exposure to infusional hazardous drugs in healthcare staff[J].Cochrane Database Syst Rev,2018,3(3):1-82.
[34] AAOHN Position Statement.Ensuring the health and safety of workers when handling hazardous drugs[J].Workplace Health Saf,2021,69(5):237-238.
[35] 中华人民共和国国务院.医疗废物管理条例[J].中国护理管理,2003(3):30-33.
[36] 卫生部发布执行新的《医院感染管理办法》[J].西部医学,2006(6):719.
[37] 中华人民共和国国务院.护士条例[J].中国护理管理,2008(3):5-7.
[38] 李国民. 《中华人民共和国基本医疗卫生与健康促进法》的伦理学解读[J].中国医学伦理学,2021,34(9):1165-1167,1193.
[39] 赵将,王雁,郭萍利,等.陕西省护理人员化疗职业防护知信行调查[J].中国卫生质量管理,2022,29(6):45-49.
[40] 徐春兰,倪静玉,万静波,等.肿瘤科化疗护理资质准入在新入职护士培训中的应用[J].齐鲁护理杂志,2018,24(19):83-85.
[41] 徐艳,王秀兰.行动研究在非肿瘤科护士化疗防护中的应用[J].护士进修杂志,2020,35(1):29-33.
[42] 马素素,陈晓燕,潘欢.化疗药物接触对临床护士健康的损害及防护现状调查[J].工业卫生与职业病,2022,48(3):192-194,198.
[43] ABU SHAROUR L,SUBIH M,BANI SALAMEH A,et al.Predictors of Chemotherapy Safe-Handling Precautions and Knowledge Among a Sample of Jordanian Oncology Nurses:A Model-Building Approach[J].Workplace Health Saf,2021,69(3):115-123.
[44] BENOIST H,BUSSON A,FAVEYRIAL A,et al.Perception,knowledge,and handling practice regarding the risk of exposure to antineoplastic drugs in oncology day hospitalization units and compounding unit staff[J].J Oncol Pharm Pract,2022:1-8.
[45] DEJOY D M,SMITH T D,WOLDU H,et al.Effects of organizational safety practices and perceived safety climate on PPE usage,engineering controls,and adverse events involving liquid antineoplastic drugs among nurses[J].J Occup Environ Hyg,2017,14(7):485-493.
[46] TOMKINS J.Ensuring health care worker safety when handling hazardous drugs:the joint position statement from the oncology nursing society,the american society of clinical oncology,and the hematology/oncology pharmacy association[J].J Oncol Pract,2015,11(4):278-279.
[47] SOEFJE S,RICKABAUGH K,RAJKUMAR R,et al.Evaluation of closed-system transfer devices in reducing potential risk for surface contamination following simulated hazardous-drug preparation and compounding[J].Int J Pharm Compd,2021,25(6):515-522.
[48] EISENBERG S.USP <800> and strategies to promote hazardous drug safety[J].J Infus Nurs,2018,41(1):12-23.
[49] 徐波,黎贵,张淑香.规范化疗职业防护保障护士自身安全[J].中国护理管理,2014,14(6):569-572.
[50] 张弦. 生物安全柜的分类和使用注意事项[J].品牌与标准化,2022(4):105-107.
[51] NOURI A,SEYED JAVADI M,IRANIJAM E,et al.Improving nurses' performance in the safe handling of antineoplastic agents:A quasi-experimental study[J].BMC Nurs,2021,20(1):1-5.
[52] KHAIRA M,GUY A L.Closed-system transfer device use with oncology biologics:A survey of Canadian healthcare practitioners[J].J Oncol Pharm Pract,2022,28(4):805-815.
[53] FORGES F,BLANC E,RAYMOND B,et al.Evaluation of a safe infusion device on reducing occupational exposure of nurses to Antineoplastic drugs:A comparative prospective study.Contamoins-1[J].Int Arch Occup Environ Health,2021,94(6):1317-1325.
[54] ISOPP standards of practice.Safe handling of cytotoxics[J].J Oncol Pharm Pract,2007,(13):1-81.
[55] POLOVICH M.USP General Chapter <800>:Considerations for Oncology Nursing Practice[J].Semin Oncol Nurs,2020,36(3):1-6.
[56] 丁锦,黄小奇,甘栩.静配中心药物规范化调配的方法探讨[J].当代护士(中旬刊),2020,27(7):188-189.
[57] 汪文静,王志敏,彭艳红,等.智能配药机器人在化疗药物配制中的应用效果[J].全科护理,2021,19(15):2097-2100.
[58] SLUSSER K,RODRIGUEZ A L.Introduction:Perspectives on the oncology nursing workforce[J].Semin Oncol Nurs,2020,36(3):1-2.
[59] FRIESE C R,YANG J,MENDELSOHN-VICTOR K,et al.Randomized Controlled Trial of an Intervention to Improve Nurses' Hazardous Drug Handling[J].Oncol Nurs Forum,2019,46(2):248-256.
[60] TRUANT T.Equity in cancer care:Strategies for oncology nurses[J].Nurs Clin North Am,2017,52(1):211-225.